Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Fluidigm

Fluidigm Corporation focuses on the most pressing needs in translational and clinical research, including cancer, imm... read more Featured Products: More products

Download Mobile App




Genetic and Lifestyle Factors Effect Biomarker Variation

By LabMedica International staff writers
Posted on 01 Sep 2014
Ideal biomarkers used for disease diagnosis should display deviating levels in affected individuals only and be robust to factors unrelated to the disease.

A detailed understanding of potential confounding factors and their effect size is therefore a necessary prerequisite in the evaluation of the rapidly growing number of candidate biomarkers.

Scientists at the Uppsala University (Sweden) analyzed 92 potential protein biomarkers for cancer and inflammation in plasma from 1,005 individuals in a longitudinal cross-sectional population-based study. More...
The biomarkers analyzed constituted an exploration panel directed against multiple cancers and also contain proteins implicated in autoimmune diseases such as rheumatoid arthritis (RA) and Graves’ disease.

For the proximity extension assay protein levels in plasma were analyzed using the Proseek Multiplex Oncology I 96 × 96 kit (Olink Bioscience; Uppsala, Sweden) and quantified by real-time polymerase chain reaction (PCR) using the BioMark HD) real-time PCR platform (Fluidigm; South San Francisco, CA, USA). The team selected 100 individuals, for Whole-Exome Sequencing using the SureSelect system for exome capture (Agilent; Santa Clara, CA, USA) and the SOLiD 5500xl instrumentation for sequencing (Applied Biosystems; Foster City, CA, USA).

The scientists found that for 75% of the biomarkers, the levels are significantly heritable and genome-wide association studies identified 16 novel loci and replicate two previously known loci with strong effects on one or several of the biomarkers. Integrative analysis attributes as much as 56.3% of the observed variance to non-disease factors. They proposed that information on the biomarker-specific profile of major genetic, clinical and lifestyle factors should be used to establish personalized clinical cutoffs, and that this would increase the sensitivity of using biomarkers for prediction of clinical end points.

Stefan Enroth, PhD, the lead author of the study, said, “These results are important, as they show which variables are significant for variations in the measurable values. If these factors are known, we have a greater possibility of seeing variations and we get clearer breakpoints between elevated values and normal values. By extension this may lead to the possibility of using more biomarkers clinically.” The study was published on August 22, 2014, in the journal Nature Communications.

Related Links:

Uppsala University
Olink Bioscience 
Fluidigm 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
POC Immunoassay Analyzer
Procise DX
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.